Dexamethasone in COVID-19: Should we consider a "golden hour" practice? | Int J Clin Pract;75(11): e14672, 2021 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Dexamethasone in COVID-19: Should we consider a "golden hour" practice?

Akinosoglou, Karolina; Gogos, Charalambos.

Akinosoglou K; Department of Medicine and Infectious Diseases, University of Patras, Rio, Greece.
Gogos C; Department of Medicine and Infectious Diseases, University of Patras, Rio, Greece.

Int J Clin Pract ; 75(11): e14672, 2021 Nov.

Article in English | MEDLINE | ID: covidwho-1476203

Subject(s)

COVID-19 Drug Treatment; Hypoglycemia; Dexamethasone; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hypoglycemia Limits: Humans Language: English Journal: Int J Clin Pract Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Ijcp.14672

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hypoglycemia Limits: Humans Language: English Journal: Int J Clin Pract Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Ijcp.14672